The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
AACR 2024 | The future of CAR T-reg cells: organ transplantation & autoimmune disease
In this video, Zinaida Good, PhD, Stanford University, Stanford, CA, briefly discusses some settings in which CAR-T regulatory (CAR T-reg) cells hold therapeutic potential, such as organ transplantation and autoimmune disease. Dr Good highlights the necessity of developing protocols that will ensure the purity and stability of CAR T-regs. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
